Prescription drug expenditures in the United States: The effects of obesity, demographics, and new pharmaceutical products

Southern Economic Journal

Volumn 73, Issue 2, 2006, Pages 515-529

  Vandegrift, Donald ^a   Datta, Anusua ^b  

^a Department of Health and Exercise Science   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750905919     PISSN: 00384038     EISSN: None     Source Type: Journal    
DOI: 10.2307/20111904     Document Type: Article

References (29)

1. Berndt, Ernst. 2001. The U.S. pharmaceutical industry: Why major growth in times of cost containment? Health Affairs 20:100-14.
2. Berndt, Ernst. 2002. Pharmaceuticals in U.S. health care: Determinants of quantity and price. Journal of Economic Perspectives 16:45-66.
3. Bureau of Labor Statistics. 2003. "Local Area Unemployment Statistics." Accessed 8 February 2004. Available at http://www.bls.gov/lau/ home.htm.
4. Centers for Medicare and Medicaid Services. 2002. "1998 State Estimates - All Payers - Prescription Drugs." Accessed 10 September 2002. Available at http://cms.hhs.gov/statistics/nhe.
5. Cockburn, lain M. 2004. The changing structure of the pharmaceutical industry. Health Affairs 23:10-22.
6. Coulson, N. Edward, and Bruce C. Stuart. 1995. Insurance choice and the demand for prescription drugs. Southern Economic Journal 61:1146-57.
7. Coulson, N. Edward, Joseph V. Terza, Cheryl A. Neslusan, and Bruce C. Stuart. 1995. Estimating the moral hazard effect of supplemental medical insurance in the demand for prescription drugs by the elderly. American Economic Review 85:122-6.
8. Danzon, Patricia M. 1997. Price discrimination for pharmaceuticals: Welfare effects in the U.S. and E.U. International Journal of the Economics of Business 4:301-21.
9. Dranove, David. 2000. The economic evolution of American health care. Princeton, NJ: Princeton University Press.
10. Elzinga, Kenneth G., and David E. Mills. 1997. The distribution and pricing of prescription drugs. International Journal of the Economics of Business 4:287-99.
11. Frank, Richard G. 2001. Prescription Drug Prices: Why do some pay more than others do? Health Affairs 20:115-28.
12. Hitt, Greg. 2002. Drug makers pour ad money into final days of campaign. The Wall Street Journal, 4 November, P. A1.
13. InterStudy Competitive Edge (Various years). HMO industry report. St. Paul, MN: InterStudy Publications.
14. Islam, Nazrul. 1995. Growth empirics: A panel data approach. Quarterly Journal of Economics 110:1127-70.
15. Kane, Nancy M. 1997. Pharmaceutical cost containment and innovation in the United States. Health Policy 41:S71-S89.
16. Kaufman, David W., Judith P. Kelly, Lynn Rosenberg, Theresa E. Anderson, and Allen A. Mitchell. 2002. Recent patterns of medication use in the ambulatory adult population of the United States. Journal of the American Medical Association 282:337-44.
17. LIMDEP version 8.0. 2002. Plainview, NY: Econometric Software, Inc.
18. Lundin, Douglas. 2000. Moral hazards in physician prescription behavior. Journal of Health Economics 19:639-62.
19. Must, Aviva, Jennifer Spadano, Eugenie H. Coakley, Alison E. Field, Graham Colditz, and William H. Dietz. 1999. The disease burden associated with overweight and obesity. Journal of the American Medical Association 282:1523-29.
20. National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. 2002. "Behavioral Risk Factor Surveillance System." Accessed 10 September 2002. Available at http://www.cdc.gov/brfss/index.htm.
21. National Institute on Alcohol Abuse and Alcoholism. 2004. "Apparent Per Capita Alcohol Consumption: National, State, and Regional Trends, 1970-2002." Accessed 8 February 2004. Available at http://www.niaaa.nih. gov/databases/consum03.htm.
22. Nestle, Marion, and Michael Jacobson. 2000. Halting the obesity epidemic: A public health policy approach. Public Health Reports 115:12-24.
23. Reinhardt, Uwe E. 2001. Perspectives on the pharmaceutical industry. Health Affairs 20:136-49.
24. Ruhm, Chrostopher J. 2003. Good times make you sick. Journal of Health Economics 22:637-58.
25. Sturm, Roland. 2002. The effects of obesity, smoking, and drinking on medical problems and costs. Health Affairs 21:245-53.
26. Suraratdecha, Chutima. 1996. A model of state-level prescription drug expenditures in the USA. Applied Economic Letters 3:289-92.
27. Thomas, Cindy P., Grant Ritter, and Stanley S. Wallack. 2001. Growth in prescription drug spending among insured elders. Health Affairs 20:265-77.
28. U.S. Bureau of the Census. (Various years). Statistical Abstract of the United States. Accessed 10 September 2002. Available at http://www.census.gov/ statab/www/.
29. Van Vliet, René C. 2001. Effects of price and deductibles on medical care demand, estimated from survey data. Applied Economics 33:1515-24.